Navigation Links
PRA International to Open Expanded Clinical Pharmacology Center
Date:2/25/2008

Newly built 80-bed facility doubles US Phase I capacity

RALEIGH, N.C., Feb. 25 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, has announced the grand opening of its expanded, newly built Clinical Pharmacology Center in Lenexa, Kansas. The company will mark the occasion with a special event at the facility on Wednesday, Feb. 27th.

The expansion doubles the Clinical Pharmacology Center's size to 80 beds, with the clinic occupying the entire first floor of PRA's Ridge Drive building near Kansas City. PRA Early Development Services has installed state-of-the-art clinical technologies and various amenities to enhance the comfort of volunteers during their participation in Phase I clinical trials at the facility.

Special guest Kansas Secretary of Commerce David Kerr will join about 200 invited area civic leaders, medical scientists, potential investigators, and PRA top executives and clinic staff members for a 3:00 p.m. official ribbon cutting and opening ceremonies. Kerr will represent the State in recognizing the clinic as a noteworthy addition in Kansas' continuing development as a leader in biosciences research.

In addition to the ribbon cutting, the event will include professionally guided facility tours and entertainment. Clinical Pharmacology Center medical leaders and clinical staff will also be on hand to answer questions during all tours.

About PRA International

PRA International is one of the world's leading global clinical development organizations, with over 3,500 employees working from offices on six continents. PRA is committed to reliable service delivery, program-level therapeutic expertise, global access to knowledge, with an involved senior management.

To learn more about PRA International, please visit http://www.prainternational.com or call our World Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as its First and Only Official Joint and Muscle Topical Cream
2. 2008 International Stroke Conference Highlights Impact of Merci Retrieval System
3. Pezcoller Foundation-AACR International Award for Cancer Research recognizes Axel Ullrich
4. Logistical information for the 2008 International Stroke Conference
5. China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results
6. ASA International Stroke Conference 2008
7. DATATRAK International Management to Host Conference Call on February 26, 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007
8. ORBIS Internationals Flying Eye Hospital Returns to Myanmar
9. Global Med Technologies(R), Inc. Adds Internationally Renowned NewYork- Presbyterian Hospital to Client List
10. Tahitian Noni International Expands HIRO(TM) Beverage Line With Super Fruits Sparkling Black Currant
11. Service Corporation International Declares Quarterly Cash Dividend

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... The Lifestyle Advisors at V... Gifts to ease the stress of finding that perfect ...the DIY treatments in health, fitness and wellness...e on time and within budget. , ...son mySpaShop (mSS), has gathered an assortment ...
(Date:12/3/2009)... Mailing a five pound gift a...llars for postage. Now the worldwide postage is f... gift book purchased online at www.oakanahouse.co... 2009 -- Mailing a five pound gift to Paris, Perth...ostage. But that,s 40 dollars they can keep in th...
(Date:12/2/2009)... , GRAND RAPIDS, Mich., Dec. 3 /PRNewswire/...s have determined precisely how the plant hormone ...o help plants respond to environmental stresses su... in the journal Nature , could help engineer crop...ld and combat global food shortages. The findings...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Re...h report is available in its catalogue: ,, Poi...nker.com/p0166822/Point-of-Care-Diagnostics.html ...he point of care (POC) diagnostics industry ,, .... POC diagnostics industry ,, Covers federal r...
(Date:12/2/2009)... , BOSTON, Dec. 2 ...site traffic rises 8%. According to Coremetrics, ...ose 13.7 percent on Cyber Monday compared to Cyber...oston,s Bella Sante Day Spas who reported today ...onday Internet sales rose 59%" - said Tiffany Amor...
Breaking Medicine News(10 mins):Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 2Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 3Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 4Health News:Greg Lawson Americana Photography Gift Books Now Offered with Free Shipping Worldwide 2Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 2Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 3Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 4Health News:Reportlinker Adds Point of Care Diagnostics 2Health News:Reportlinker Adds Point of Care Diagnostics 3Health News:Reportlinker Adds Point of Care Diagnostics 4Health News:Reportlinker Adds Point of Care Diagnostics 5Health News:Reportlinker Adds Point of Care Diagnostics 6Health News:Reportlinker Adds Point of Care Diagnostics 7Health News:Reportlinker Adds Point of Care Diagnostics 8Health News:Reportlinker Adds Point of Care Diagnostics 9Health News:Reportlinker Adds Point of Care Diagnostics 10Health News:Reportlinker Adds Point of Care Diagnostics 11Health News:Reportlinker Adds Point of Care Diagnostics 12Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 2Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 3
.... 4 HEI, Inc. (Nasdaq: HEII,-- http://www.heii.c...e of,substantially all of the assets of its RFID d...owned subsidiary of Dutch based Smartrac N.V. The,...er lists, and the assumption of substantially all ...
...ng to be Held September 20, 2007, READING, Pa., S...today urged shareholders to vote in favor of its,p...YSE: TFX ) and for the,reelection of the current ... B. Fleck, President,and Chief Executive Officer, ...
...eptember 4, 2007) The results of a clinical trial...trics, indicates that, when used as part of routin...ive in slowing down lung disease in children with ... Health Centre, the multi-centre study monitored 1...
...t. 4 WellPoint, Inc. (NYSE:,WLP) announced today ...the,following conferences: * Bear Stearns 20th An... beginning at 2:00 p.m. Eastern Daylight Time (E...* Merrill Lynch Global Pharmaceutical, Biotech & M...
...gotiation with Carticept for Commercialization and...l Medical Market, LIVINGSTON, N.J., Sept. 4 Mile...today announced that it has,successfully concluded...he treatment of arthritic joints. Work under,the C...
...- A combination of two drugs shows promise in trea... that originates in the eye and spreads to other o...sity Comprehensive Cancer Center researchers. , ... cancer cell death. , Metastatic uveal melanoma, ...
Other Medicine News:Health News:HEI, Inc. Closes on Sale of RFID Division Assets 2Health News:Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors 2Health News:Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors 3Health News:Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors 4Health News:Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors 5Health News:WellPoint Announces Appearances at Upcoming Conferences 2Health News:Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical 2Health News:Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical 3Health News:Promising drug combination may help those with ocular melanoma that has spread 2
(Date:12/2/2009)..., LITTLE FALLS, N.J., Dec. 2 /PRNewswire-FirstCal...ease the results for its first quarter ended Octob... and hold a conference call to discuss the results...e Charles M. Diker, Chairman; Andrew A. Krakauer, ...resident; Craig A. Sheldon, Senior Vice President,...
(Date:12/2/2009)... , LEXINGTON, Mass. and HEIDELBERG, Germany, De...cognized as one of the winners of the "Top 10 Inno...company,s automated sequence capture technology fo...ts exceptional combinations of invention, vision a...l of expert judges to evaluate a broad range of li...
(Date:12/2/2009)..., LAKE FOREST, Ill., Dec. 2 /PRNewswire-FirstCa...vider of clinical information and medication deliv...ired Salt Lake City-based TheraDoc, a clinical inf...ce systems. TheraDoc,s two leading products, Infec...t(TM), join Hospira,s expanding portfolio of medic...
Breaking Medicine Technology:Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009 2The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009' 2Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 2Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 3Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 4Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 5Human Genome Sciences Announces Proposed Public Offering of Common Stock 13215 1Human Genome Sciences Announces Proposed Public Offering of Common Stock 13215 2Human Genome Sciences Announces Proposed Public Offering of Common Stock 13215 3Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 1Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 2Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 3Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 4Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 5Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 6Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 7Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 8Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 9Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 10Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 11Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 12Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 13Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 14Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 15Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 16Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 17Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 18Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 19Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 20Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 21Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 22Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 23Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 24Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 25Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 26Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 27FRC Action to Host Webcast on the Government Takeover of Health Care 52830 1FRC Action to Host Webcast on the Government Takeover of Health Care 52830 2
...ifornia, 23 May 2007 - The antidepressant duloxeti... painful symptoms in,depressed patients who did no...nt with a selective serotonin reuptake,inhibitor (...witched from an SSRI abruptly or gradually. 1 Thi...chiatric,Association’s 160 th Annual Meetin...
...s.--(BUSINESS WIRE)--May 24, 2007 - ImmunoGen, Inc... develops targeted,anticancer therapeutics using i... announced that clinical findings for three,differ...s are to be,reported at the 43rd American Society ... place June 1-5, 2007 in Chicago, IL., Trastuzumab...
Other Medicine Technology:In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 2In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 3In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 4In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 5In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 6In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 7In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 8In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 9ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 2ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 3
Toxo IgM EIA
Toxo IgG EIA
Pylori Detect IgG EIA
MonoFluo Legionella pneumophilia IFA Test
Medicine Products: